Figure 7 compares lipidomics data from 7 lipid species that showed differences in multiple brain regions in the current study to those same lipids in (e.g., HYP, CER, STR, THAL, CTX, and HIPP) of FAAH KO (Leishman et al., 2016), MAGL KO (Leishman et al., 2016), ABHD12 KO (Leishman et al., 2019), NAPE-PLD KO (Leishman et al., 2016), CB1 KO (Leishman et al., 2016), acute 3 mg/kg THC treatment (Leishman et al., 2018), and acute 3 mg/kg CBD treatment (Leishman et al., 2018)
The disadvantage is the precision problem
The market is growing due to the rising prevalence of diabetes and obesity, driving demand for effective treatment options
Long-term Management and Prevention of Deficiencies Managing Vitamin B12 and iron deficiencies needs a full plan
Cana: canagliflozin